On march 7, 2018 Perrigo Company plc (NYSE; TASE: PRGO) reported that Ron Winowiecki, Perrigo Chief Financial Officer, will present at the 2018 Barclays Global Healthcare Conference at 1:35 PM EST on Tuesday, March 13, 2018 (Press release, Perrigo Company, MAR 7, 2018, View Source [SID1234524486]). Mr. Winowiecki will also present at the 28th Annual Oppenheimer Healthcare Conference at 9:45 AM EST on Tuesday, March 20, 2018. Interested parties can access the presentation webcasts at View Source

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On March 7, 2018 Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, reported that Christopher K. Mirabelli, Ph.D, Chairman, President, and Chief Executive Officer, will present a corporate overview at the Barclays Global Healthcare Conference, being held in Miami on March 13-15, 2018 (Press release, Leap Therapeutics, MAR 7, 2018, View Source;p=RssLanding&cat=news&id=2336702 [SID1234524483]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2018 Barclays Global Healthcare Conference – Leap Presentation Details:
Date: Wednesday, March 14, 2018
Time: 2:05 P.M.

The presentation will be webcast live and may be accessed on the Investors page of the company’s website at www.investors.leaptx.com, where a replay of the event will also be available for a limited time.

On March 7, 2018 Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, reported that company management will present at two investor conferences in March (Press release, Insmed, MAR 7, 2018, View Source [SID1234524482]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 38th Annual Health Care Conference in Boston, MA on Wednesday, March 14, 2018 at 10:40 a.m. ET
Oppenheimer’s 28th Annual Healthcare Conference in New York, NY on Wednesday, March 21, 2018 at 11:30 a.m. ET
A live audio webcast of both presentations will be available by visiting the Investors section of Iovance Biotherapeutics’ website at View Source A replay of the webcasts will be archived on Iovance Biotherapeutics’ website for 30 days following the presentations.

on march 7, 2018 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE American: IMUC) reported that it plans to report fourth quarter and full year 2017 financial results on Tuesday, March 13, 2018 (Press release, ImmunoCellular Therapeutics, MAR 7, 2018, View Source [SID1234524481]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Company also plans to hold a conference call and webcast on that day at 5:00 pm ET to discuss the 2017 financial results and provide a business update. The call will be hosted by Anthony Gringeri, PhD, President and CEO.

LIVE CALL:

(877) 853-5636 (toll-free); international dial-in: (631) 291-4544; conference code 4075529.

WEBCAST:

Interested parties who wish to listen to the webcast should visit the Investor Relations section of ImmunoCellular’s website at www.imuc.com, under the Events and Presentations tab. A replay of the webcast will be available one hour after the conclusion of the event.

ImmunoCellular Therapeutics Logo. (PRNewsFoto/ImmunoCellular Therapeutics) (PRNewsFoto/IMMUNOCELLULAR THERAPEUTICS)

The conference call will contain forward-looking statements. The information provided on the teleconference is accurate only at the time of the conference call, and ImmunoCellular will take no responsibility for providing updated information except as required by law.

On March 7, 2018 GlycoMimetics, Inc. (Nasdaq: GLYC) reported that it will present at four investor conferences during the month of March, including (Press release, GlycoMimetics, MAR 7, 2018, View Source [SID1234524480]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

30th Annual ROTH Conference
March 11 – 14, 2018, The Ritz Carlton, Dana Point, CA
CFO Brian Hahn will present on March 12 at 3:30 p.m. PT.

Cowen 38th Annual Health Care Conference
March 11 – 14, 2018, Copley Place Marriott, Boston, MA
CEO Rachel King will present on March 14 at 9:20 a.m. ET.

BioCentury: 25th Annual Future Leaders in the BioTech Industry
March 23, 2018, Millennium Broadway Hotel & Conference Center, New York, NY
Mrs. King will present in room 311 at 2:30 p.m. ET.

Needham & Company’s 17th Annual HealthCare Conference
March 27 – 28, 2018, Westin Grand Central Hotel, New York, NY
Mrs. King will present on March 27 at 8:00 a.m. ET.